Sarasota, FL, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market by Test Type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA and Competitive (ELISA) for Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantification and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022”. According to the report, global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market was valued at approximately USD 437.6 million in 2016 and is expected to generate revenue of around USD 547.6 million by end of 2022, growing at a CAGR of around 4.6% between 2017 and 2022.
Enzyme linked immunosrbent assay (ELISA) is a test that detects and/or quantifies antibodies in the biological samples. This test can be used to determine if the sample has antibodies related or generated against specific antigen related to the certain infectious condition. Antibodies are proteins that are produced against foreign pathogen as an immunogenic response to harmful substances called pathogen. ELISA is a biochemical reaction in which antigen is adsorbed on a solid surface. An antibody linked to an enzyme is allowed with the antigen and is detected by adding a substrate specific to the linked enzyme. ELISA test plays very important role in the diagnosis of viral infections such as HIV, varicella-zoster virus, which causes chickenpox and shingles, rotavirus, Zika virus, syphilis etc. ELISA is often used as a screening tool before more in-depth tests are carried out. ELISA also can be used in pharmaceutical quality control tests such as endotoxin tests, protein quantification.
Browse through 29 Market Tables and 20 Figures spread through 110 Pages and in-depth TOC on "Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, 2016 – 2022”.
Request Free Sample copy of Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Report @ https://www.zionmarketresearch.com/sample/enzyme-linked-immunosorbent-assay-testing-market
Global Enzyme-Linked Immunosorbent Assay (ELISA) testing market is primarily driven by the emergence of cost effective technologies and laboratory automation for ELISA assay. Other major driving factors are increasing research and development on biomarkers and monoclonal antibodies (MAbs) coupled along with continued growth in drug discovery market. However, the threat of substitution by new technologies such as multiplex proteomic array platforms is the major restraints that may limit the growth of the market. Nonetheless increasing the need for accurate and early disease diagnosis owing to increasing burden of chronic diseases across the globe along with increasing geriatric population base are likely to disclose the new avenues for Enzyme-Linked Immunosorbent Assay (ELISA) testing market in the near future.
The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is segmented on the basis of different test types such as sandwich ELISA, indirect ELISA, multiple and portable ELISA and competitive ELISA. Indirect ELISA segment is expected to grow at fastest rate in the global market over the forecast period.
Browse the full "Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market by Test Type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA and Competitive (ELISA) for Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantification and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022?" report at https://www.zionmarketresearch.com/report/enzyme-linked-immunosorbent-assay-testing-market
Immunology, inflammation, infectious diseases, cancer, protein quantification and other are the key applications of the global ELISA testing Market. The Immunology segment dominated the market in terms of revenue in 2016.
North America represents developed regional markets for enzyme-linked immunosorbent assay (ELISA) testing and is expected to see the rapid growth in the years to come. The U.S. is by far the leading enzyme-linked immunosorbent assay (ELISA) testing market by country in North America. The U.S. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to the well-developed healthcare infrastructure and increases in research and development on enzyme-linked immunosorbent assay (ELISA) testing. Moreover, the disposable income and reimbursement of life threatening diseases are very high in this region which promotes the growth of enzyme-linked immunosorbent assay (ELISA) testing market.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/enzyme-linked-immunosorbent-assay-testing-market
Europe was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to growing number of population with lifestyle disorders.
Asia Pacific is expected to witness noticeable growth in the near future. In Asia, China, India, and Japan will continue to be the fastest growing markets in enzyme-linked immunosorbent assay (ELISA) testing market. Growth in Asia Pacific market is expected to be driven by increasing geriatric population base with a high prevalence of chronic diseases, increasing expenditure in research and development and increasing disposable income.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/1978
In Middle East & Africa; African region is projected to register noticeable growth owing to increased government funding and high burden of diseases such as HIV and other infectious diseases. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the aforementioned parameters are expected to propel the market growth in this region.
Some of the key players in Enzyme-Linked Immunosorbent Assay (ELISA) testing market include Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.
Directly Purchase a copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/enzyme-linked-immunosorbent-assay-testing-market
This report segments the global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market as follows:
Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market: Test Type Segment Analysis
- Sandwich ELISA
- Indirect ELISA
- Multiple and portable ELISA
- Competitive ELISA
Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market: Application Segment Analysis
- Infectious diseases
- Protein quantification
Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
- Hepatitis C Drug Market: https://www.zionmarketresearch.com/report/hepatitis-c-drug-market
- Leukemia Therapeutics Market: https://www.zionmarketresearch.com/report/leukemia-therapeutics-market
- Myocardial Infarction Treatment Market: https://www.zionmarketresearch.com/report/myocardial-infarction-treatment-market
- Melanoma Drugs Market: https://www.zionmarketresearch.com/report/melanoma-drugs-market
- Antifungal Drug Market: https://www.zionmarketresearch.com/report/antifungal-drug-market
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
CONTACT: Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: firstname.lastname@example.org Website: https://www.zionmarketresearch.com